Senior Specialist US & Global Rare Disease Market Engagement - DHH
Merck
Summary
This role resides within the Digital Human Health (DHH) US & Global Market Engagement Team, providing strategic thought-partnership to US/Global commercial stakeholders through understanding brand strategy and co-creating DHH demand and business requirements aligned to business priorities. The team quarterbacks demand fulfillment and leads activation of DHH products and services.
Job description
The Senior Specialist will develop and communicate data-driven, actionable insights that drive greater customer and market understanding to inform launch and go-to-market strategies and help meet commercial objectives.
Primary Responsibilities
- Translate business needs and priorities to build analytical plans that answer business questions by providing actionable insights.
- Effectively communicate advanced analytics to stakeholders to inform business decisions.
- Communicate and collaborate effectively with cross-functional teams with competencies in market research, forecasting, commercial analytics, data science, customer engagement, data strategy, population health, competitive insights, marketing operations, and medical/clinical backgrounds.
- Stay current with industry trends and advancements in analytical methodologies to bring new ideas forward (including application of GenAI) that enhance analytic capabilities.
- Contribute to innovative experiments including idea generation, idea incubation and/or experimentation, identifying tangible and measurable criteria to improve business processes and strategies.
- Derive actionable business insights from various data sources, develop clear data stories, and communicate effectively to business stakeholders.
- Identify the data, analytics and research needs to define, enable, and inform commercial strategies of brand and business leaders.
Preferred Experience and Skills
- Domain knowledge in Pulmonary Hypertension or Rare Disease, specifically as it relates to data analytics.
- Entrepreneurial spirit, consultative and strategic mindset, experience in Rare Disease and technology (AI, agentic etc.), and a demonstrated record of producing actionable insights from analytics.
- Proven data science experience leveraging advanced statistical methods, Machine Learning/Artificial Intelligence, Natural Language Processing (NLP) modeling and model evaluation.
Requirements
- BS (or equivalent) in Data Science, Mathematics, Economics, Computer Science, Statistics, Decision Science, Marketing, Engineering, Public Health, or equivalent scientific/commercial discipline
- 3+ years of relevant experience delivering complex analytical projects in the pharmaceutical, biotech, consulting, or healthcare industry
- Knowledge in mining patient medical claims/EMR data with a strategic mindset and proven record of producing actionable business insights
- Self-motivated, proactive mindset, and ability to work independently
- Effective interpersonal skills, communication skills, and stakeholder management, including experience collaborating in a matrixed organization
- Strong business acumen and consultative skills
- Effective organizational and project management skills
- Innovative thinking with affinity toward experimentation and appropriate risk-taking
- Awareness of the opportunities, limitations, and responsible use of AI in a regulated environment
- Prior hands-on experience working with healthcare data especially EMR/EHR, Claims Data (i.e. IQVIA APLD) and various data offerings
- Ability to develop efficient programming code and software assets that provide advanced analytical functionality
- Knowledge of machine learning and descriptive algorithms/modeling using Python, R studio, SAS, SQL etc.
- Travel may be required <20%
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Retirement Benefits
- Paid Holidays
- Vacation
- Compassionate & Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.